For media inquiries please contact:
Our team brings a founder's mentality and client-centered focus united by a common cause, entrepreneurial spirit, and a passion for customer service. Our unique combination of industry experience, technical acumen, and operational wisdom sets the stage for client success and benefits to patients around the globe. We believe these characteristics should influence everything we do in business and life. We love the work that we do, and our clients should reap the benefits.
Pat brings over thirty-five years of experience in the healthcare industry directing pharmaceutical manufacturing operations globally in parenteral, API, specialty pharmaceutical, formulation, manufacturing, and analytical contract development organizations. Prior to Alcami, he was co-founder and CEO of TriPharm Services, a parenteral manufacturing business acquired by Alcami. From 2015 to 2019, Mr. Walsh was the Chief Executive Officer of Avista Pharma Solutions, a private equity-backed global provider of contract manufacturing, development, and analytical testing services acquired by Cambrex in January 2019. Pat was named Chief Executive Officer of AAIPharma Services Corporation in 2010 and led the company through an impressive growth trajectory, culminating in the sale of the company in 2014. Prior executive roles also include CEO of Kadmus Pharma (acquired by Organon) and President and COO of Gensia-Sicor (acquired by Teva).
In addition to his duties at Alcami, Pat serves as Chairman of the Board of specialty pharma company ANI Pharmaceuticals (NASDAQ: ANIP), an independent director of Landec Corporation (NASDAQ: LNDC), and private equity backed Institute Chemica Emiliano (I.C.E.) based in Milan Italy. He is also an Operating Partner at healthcare private equity firm Ampersand Capital. Prior board of director roles includes serving as Chairman of Brammer Bio, MedPharm Ltd, and numerous other pharma and biotechnology companies over the course of his career.
Eric has over thirty years of industry experience and a proven track record of leadership in building successful, high-growth companies in partnership with private equity firms, which have resulted in significant value creation for shareholders. He most recently served as CFO for TriPharm Services, which was acquired by Alcami in January 2020. Before TriPharm, he was CFO of Avista Pharma Solutions, where he played a key role in the expansion and sale of the company. Before Avista, he was CFO of Mayne Pharma US, a publicly-traded company operating in the generic, brand, and CDMO pharmaceutical industries, and, at private-equity backed AAIpharma Services, where he supported a successful expansion strategy. Other prior pharmaceutical leadership roles include CFO of Patheon Inc, a publicly-traded and private equity-backed CDMO at the time, and various senior finance roles with Novartis, including CFO of Sandoz Pharmaceuticals, Vice President and Controller of Novartis Pharmaceuticals and Vice President Finance of Novartis Pharmaceuticals.
Mr. Compton brings over twenty-five years of industry experience with an extensive background in leading commercial operations. Before joining Alcami, Mr. Compton was the Chief Commercial Officer at Avid Bioservices, Inc. (NASDAQ: CDMO), a contract large molecule bulk drug substance development and manufacturer. From 2015 to 2019, Mr. Compton was the Vice President of Sales and Marketing at Avista Pharma, a private equity-backed global provider of contract manufacturing, development, and analytical testing services acquired by Cambrex. Mr. Compton also served in numerous executive leadership roles at AAIPharma Services Corporation, a predecessor company to Alcami, from 2010 to 2014. During the first 10-years of his career, he supported small innovator biotech/pharma start-up companies, advancing drugs from discovery to the clinic. Prior to embarking on a career in commercial operations, his last scientific role was Director of Analytical Development at Kadmus Pharmaceuticals.
Timothy holds a B.S. in Microbiology from Washington State University and is an active duty veteran of the U.S. Army.
Ken joined Alcami in March of 2020 as the Executive Vice President of Drug Product Operations overseeing all drug product manufacturing facilities for Alcami. Ken has over 35 years in the pharmaceutical industry, of which 20 years were with Teva Parenteral Medicines and Gensia Sicor. Before Alcami, Ken served in ever-increasing responsibilities for Avista Pharma, including Chief Operations Officer and Active President of the early-stage business group encompassing 5 locations for Cambrex. Ken has served in various executive roles, including Vice President of Quality, Vice President of Operations, and Vice President of Process Engineering & Validation. He has led global organizations with hands-on experience, including validation of systems, equipment, cleaning, product, and processes in support of facility startups and new product introductions. During his tenure at Teva Parenteral Medicines, Ken led and provided significant direction in the build-out of a dedicated high potency facility, a facility for sterile suspensions as well as a facility for the manufacture of sterile emulsions. Ken also led automation efforts for the quality support systems as part of the facility and system design and enhancements. Ken has led numerous successful FDA, EMEA, MCA, and other international cGMP inspections. Ken holds a B.S. in Biology/Life Sciences from Niagara University.
Louise brings over 25 years of industry experience with a successful track record of driving results in drug development and manufacturing operations. Before joining Alcami, she was Vice President of Global Program Management and KBI Biopharma where she led a global team supporting the client interface for biologics drug substance development programs. Prior to that, Louise was the VP, CMC and Program Management at Locus Biosciences, where she led their strategic initiative to in-source GMP manufacturing supporting Pre-Clinical and Phase I clinical trials and established CMC Department focused on developing drug substance and drug product processes for revolutionary bacteriophage technology. In over 14 years with Patheon, Louise held various roles of increasing responsibility in Pharmaceutical Development Services and Project Management. Louise has a Bachelor of Science in Microbiology from the University of Waterloo and a Project Management Professional (PMP) certification from the Project Management Institute.
Katie brings over 25 years of experience in leading laboratory teams. Before returning to Alcami in June 2020, Katie worked for two years at Avista Pharma Solutions/Cambrex where she led the Analytical Development Service team to over 46% year over year growth. She started her career with AAIPharma (now Alcami) in Wilmington as an Assistant Scientist and has progressed through every level of the career ladder. While at AAIPharma, some of her many accomplishments included, implementing 5S principles and streamlining processes, introducing and maintaining Key Performance Indicators (KPI) and metrics, and implementing training and mentoring solutions within the lab teams. Katie holds a Bachelors's and Masters's of Chemistry from the University of North Carolina in Wilmington.
Elliott is a world expert in analytical operations with over 18 years of industry experience and a successful track record of leading laboratory operations. Before joining Alcami, he was Vice President and Site Director at Cambrex where he was responsible for leading their Durham, NC site which offers analytical services from R&D through commercial as well as early-phase drug substance development and manufacturing. Prior to this, he was the Executive Director of Analytical Services at Avista Pharma. Elliott received his BS in Biomedical Chemistry from Oral Roberts University and Ph.D. in Chemistry from Northern Illinois University.
Brian returns to Alcami as our Vice President of Regulatory Affairs and Quality Assurance after spending two years leading quality assurance, regulatory, and compliance teams at Noramco. He brings over 30 years of industry experience and a proven track record of success in upholding the world’s highest standards in sterile product manufacturing, solid oral dosage manufacturing, and API manufacturing. Brian's depth of experience includes oversight of Laboratory Quality, Manufacturing Quality, Regulatory and Compliance, Business Quality, generic product development programs, and implementation and management of Commercial Product Quality Systems. Brian was employed by AAI Pharma/Alcami for 24 years and has been involved in the successful management of over 35 regulatory inspections. Brian holds a Bachelor of Science degree in Chemistry from Carson-Newman College and a Master's degree in Business Administration from the University of North Carolina Wilmington.
Jacque joined Alcami in January of 2020 as the Vice President of Quality Operations. Before joining Alcami, she was the Vice President of Quality at TriPharm Services and was responsible for all Quality and Compliance aspects of the company’s parenteral manufacturing operation and related testing. Before this, she used her depth of industry experience as a consultant for private equity firms. Prior to this, she oversaw the Quality and Compliance of externally manufactured Commercial sterile products for Gilead Sciences, which encompassed aseptic processing, blow-fill-seal, and medical device operations, which totaled sixteen sites globally. Before Gilead, she was the Site Head of quality for the AAIPharma aseptic manufacturing facility located in Charleston, SC. Jacque holds a Bachelor of Science degree in Biology from the University of South Carolina.
Before joining Alcami, Chad was the Director, Operations at LSNE Contract Manufacturing, responsible for aseptic and non-aseptic pharmaceuticals and medical devices manufacturing across two sites. Previously, he held roles as the Filling and Lyophilization Manager at Xellia Pharmaceuticals and Biologic Operations Manager at Pfizer. Chad began his career in the United States Air Force as a Calibration Technician. Chad holds a Bachelor of Science in Management from Cornerstone University.
Dave brings over 20 years of IT leadership experience with a successful track record of implementing and improving IT systems utilized in cGMP environments. Before joining Alcami, he was the Director of Information Technology for private-equity backed BestCo, a consumer health manufacturing company. In this role, he was responsible for all IT infrastructure, operations, security, and systems within the organization. Before this, Dave held IT leadership roles in the generics division of Endo Pharmaceuticals, including Par Pharmaceuticals and Qualitest Pharmaceuticals. Dave received an MBA from the University of North Carolina Chapel Hill and a BS in Computer Science from Arcadia University.
Dawn has a breadth of HR expertise across 20 years that encompasses several industries, large and small companies, and both US and international responsibilities. Her prior experience includes eight years in the Biosciences Division of Thermo Fisher Scientific and five years at Pentair. Dawn has a track record of successfully delivering results across all aspects of HR, including talent management, leadership development, employee engagement, and cultural transformations. She is a champion of open and honest dialogue and is passionate about connecting with employees, creating positive cultures, and supporting strategic initiatives that drive growth. Dawn has her BS in Management with an emphasis in Human Resources from Northern Illinois University and an MBA from Northwestern University – Kellogg School of Management.
Ken has over twenty years of experience in the pharmaceutical sector with considerable experience in finance, mergers, acquisitions, and information system implementations. Before joining Alcami, he was the Vice President and Controller of TriPharm Services, a parenteral manufacturing business acquired by Alcami. Before this, he spent twenty-two years at AAIPharma/Alcami in numerous financial leadership roles, including Vice President Financial shared services, Director of Finance, Asst. Treasurer, Financial Systems Manager, and Accounting Manager. Prior to the pharmaceutical industry, he served in roles as Plant Controller, Manager of Business Analysis, Internal Quality Auditor for ISO certification, and Cost Accountant in the pulp and paper industry. Ken has a BS in Accountancy from the University of North Carolina at Wilmington.
Bob joined Alcami in May of 2014 as the Senior Director of Engineering and Facilities and is now the Vice President of Global Engineering. Before joining Alcami, he was the Director of Engineering and Site Services at Catalent Pharma Solutions. Bob has nearly 30 years of industry experience and has held various leadership roles at Pfizer and GE Healthcare. Bob holds a Bachelor of Science degree in Chemical Engineering from North Carolina State University and a Master Certificate in Project Management from the Wisconsin School of Business.